Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones

Arkivoc

Volumn 2004, Issue 5, 2004, Pages 170-180

  Gitto, Rosaria ^a   Barreca, Maria L ^a   Francica, Eleonora ^a   Caruso, Roberta ^a   De Luca, Laura ^a   Russo, Emilio ^b   De Sarro, Giovambattista ^b   Chimirri, Alba ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

1,2,3,4 tetrahydroisoquinolinone 4 carboxylic acids; AMPA receptor; Audiogenic seizures; Glutamate

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1,2,3,4 TETRAHYDROISOQUINOLINE 4 CARBOXYLIC ACID DERIVATIVE; 3,5 DIHYDRO 7,8 DIMETHOXY 4H 2,3 BENZODIAZEPIN 4 ONE DERIVATIVE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; CARBOXYLIC ACID DERIVATIVE; ETHYL N (4' CHLOROBENZYL) 1 OXO 3 (4'' METHOXYPHENYL) 1,2,3,4 TETRAHYDROISOQUINOLINE 4 CARBOXYLATE; ETHYL N BENZYL 1 OXO 3 (4'' METHOXYPHENYL) 1,2,3,4 TETRAHYDROISOQUINOLINE 4 CARBOXYLATE; N (4' CHLOROBENZYL) 1 OXO 3 (4' METHOXYPHENYL) 1,2,3,4 TETRAHYDROISOQUINOLINE 4 CARBOXYLIC ACID; N (4' FLUOROBENZYL) 1 OXO 3 (4'' METHOXYPHENYL) 1,2,3,4 TETRAHYDROISOQUINOLINE 4 CARBOXYLIC ACID; N BENZYL 1 OXO 3 (4'' METHOXYPHENYL) 1,2,3,4 TETRAHYDROISOQUINOLINE 4 CARBOXYLIC ACID; N BENZYL 1 OXO 3 PHENYL 1,2,3,4 TETRAHYDROISOQUINOLINE 4 CARBOXYLIC ACID; PD 00735; TALAMPANEL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; AUDIOGENIC SEIZURE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MOUSE; MOUSE STRAIN; NONHUMAN;

EID: 2942631438     PISSN: 14246376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dingledine, R.; Borges, K., Bowie, D.; Traynelis, S.R. Pharmacol. Rev. 1999, 51, 7.
2. Bräuner-Osborne, H.; Egebjerg, J.; Nielsen, E. O.; Madsen, U.; Kgrogsgarard-Larsen, P. J. Med. Chem. 2000, 43, 2609.
3. Lees, G.J. Drugs 2000, 59, 33.
4. Rogawski, M.A.; Donevan, S.D. Adv. Neurol. 1999, 79, 947.
5. Chimirri, A.; Gitto, R.; Zappalà, M. Exp. Opin. Ther. Patents 1999, 9, 557.
6. Rogawski, M.A. Trends Pharmacol. Sci. 1993, 14, 325.
7. Wang, Y.; Konkoy, C.S.; Ilvy, V.I.; Vanover, K.E.; Carter, R.; Weber, E. ; Keana, J.F.W.; Woodward, R.M.; Cai, S.X. J. Med. Chem. 1998, 41, 2621.
8. De Sarro, G.; De Sarro, A.; Gitto, R.; Grasso, S.; Micale, N.; Quartarone, S.; Zappalà, M. Bioorg. Med. Chem. Lett., 1998, 8, 971.
9. Szabados, T.; Gigler, G.; Gacsalyi, I.; Gyertan, I. ; Levay, G. Brain Res. Bull. 2001, 55, 387.
10. Sólyom, S.; Tarnawa, I. Curr. Pharm. Des. 2002, 8, 913.
11. Andrási, F. Drugs Future 2001, 26, 754.
12. De Sarro, G.; Chimirri, A.; De Sarro, A.; Gitto, R.; Grasso, S.; Giusti, P.; Chapman, A.G. Eur. J. Pharmacol. 1995, 294, 411.
13. Chimirri, A.; De Sarro, G.; De Sarro, A.; Gitto, R.; Grasso, S.; Quartarone, S; Zappalà, M; Giusti, P.; Libri, V; Constanti, A; Chapman, A.G. J. Med. Chem. 1997, 40, 1258.
14. Chimirri, A.; De Sarro, G.; De Sarro, A.; Gitto, R.; Quartarone, S; Zappalà, M; Constanti, A; Libri, V. J. Med. Chem. 1998, 41, 3409.
15. Bevacqua; F., Basso, A.; Gitto, R.; Bradley, M.; Chimirri, A. Tetrahedron Letters 2001, 42, 7683.
16. Gitto, R.; Zappalà, M; De Sarro, G.; Chimirri, A. Il Farmaco 2002, 57, 129.
17. Chimirri, A.; Bevacqua, F.; Gitto, R.; Quartarone, S; Zappalà, M; De Sarro, A.; Maciocco, L.; Biggio, G.; De Sarro, G. Med. Chem. Res. 1999, 9, 203.
18. Zappalà, M.; Gitto, R.; Bevacqua, F.; Quartarone, S.; Chimirri, A.; Rizzo, M.; De Sarro, G.; De Sarro, A. J. Med. Chem. 2000, 43, 4834.
19. Chimirri, A.; Gitto, R.; Quartarone, S.; Orlando, V.; De Sarro, A.; De Sarro G.B. Il Farmaco 2002, 57, 759.
20. Gitto, R.; Orlando, V.; Quartarone, S.; De Sarro, G.; De Sarro, A.; Russo, E.; Ferreri, G.; Chimirri, A. J. Med. Chem. 2003, 46, 3758.
21. De Sarro, G.; Ferreri, G.; Gareri, P.; Russo, E.; De Sarro, A.; Gitto, R.; Chimirri, A. Pharmacol. Biochem. Behav., 2003, 74, 595.
22. De Luca, L.; Macchiarulo, A.; Costantino, G.; Barreca, M.L.; Gitto, R.; Chimirri, A.; Pellicciari, R. Il Farmaco, 2003, 58, 107.
23. Barreca, M.L.; Gitto, R.; Quartarone, S.; De Luca, L.; De Sarro, G.; Chimirri, A. J. Chem. Inf. Comput. Sci. 2003, 43, 651.
24. Gitto, R.; Barreca, M.L.; De Luca, L.; De Sarro, G.; Ferreri, G.; Quartarone, S.; Russo, E.; Constanti, A.; Chimirri, A. J. Med. Chem. 2003, 46, 197.
25. Chimirri, A.; Caruso, R.; Gitto, R.; Quartarone, S.; Orlando, V.; De Sarro G. Il Farmaco, 2004, 59, 00000
26. Ferreri, G.; Chimirri, A.; Russo, E.; Gitto, R.; Gareri, P.; De Sarro, A.; De Sarro G. Pharmacol. Biochem. & Behav. Available online 5 December 2003
27. The compound PD00735 was purchased from Maybridge plc (Trevillet, Tinatgel, UK) www.maybridge.com
28. Govindachari, T.R.; Chinnasamy, P.; Rajeswari, S.; Chandrasekaran, S.; Premila, M.S.; Natarajan, S.; Nagaragan, K.; Pai, B.R., Heterocycles, 1984, 22, 585.
29. Cushman, M.; Madaj, E.J. J. Org. Chem., 1987, 52, 907.
30. Bonnaud, B.; Carlessi, A.; Bigg, D.C.H. J. Heterocyclic Chem., 1993, 30, 257.
31. Kozekov, I.D.; Koleva, R.I.; Palamareva, M.D. J. Heterocyclic Chem., 2002, 39, 229.
32. Chapman, A. G.; Al-Zubaidy, Z. Meldrum, B. S. Epilepsy Res., 1993, 231, 301.
33. Yadav, J.S.; Reddy, B.V.S.; Saritha Raj, K.; Prasad, A.R. Tetrahedron, 2003, 59, 1805.